Itzhak Sultan ups the ante in IMAD Infinity: exercises options for about ₪400,000

Insider Itzhak Sultan increased his stake in the life sciences partnership IMAD Infinity to 17.57% after injecting about ₪400,000 through the exercise of options.

Itzhak Sultan, an insider in the IMAD Infinity Medical partnership, exercised 440,000 options and increased his stake from 13.18% to 17.57%. The move, executed at an exercise price of ₪0.90 per unit, injected about ₪396,000 into the partnership's treasury.

Itzhak Sultan, an insider in the life sciences investment partnership IMAD Infinity Medical, has significantly increased his holdings in a move that signals confidence and injects fresh capital into the partnership's treasury. According to an immediate report published by the partnership on September 29, 2026, Sultan exercised 440,000 options he held for a total investment of ₪396,000. This move strengthens Sultan's position as one of the primary unit holders in the partnership.

The transaction was executed on September 28, 2026, when Sultan converted the options into participation units at a pre-fixed exercise price of ₪0.90 per unit. As a direct result of the move, the number of participation units held by him grew from 899,381 units, which represented 13.18% of the capital, to 1,339,381 units. Sultan's current stake in IMAD Infinity now stands at 17.57% of the participation unit capital, on both a basic and fully diluted basis, as noted in the report.

Increasing a stake by an insider, particularly through the exercise of options, is considered a material event for public companies. Unlike purchasing shares on the open market, exercising options involves injecting fresh capital directly into the company's treasury. In this case, IMAD Infinity's treasury will be enriched by ₪396,000, which is expected to be used for its ongoing investment activities. Such a move demonstrates the insider's willingness to invest additional capital in the company beyond their existing holding.

IMAD Infinity Medical is a limited partnership traded on the Tel Aviv Stock Exchange (TASE: IMAD.L), which focuses on identifying and investing in early-stage start-up companies in the life sciences fields, such as medical devices and digital health. For an investment partnership of this type, expressions of confidence from key insiders are critical, as they signal stability and belief in the investment strategy and the potential of the portfolio companies. Sultan's exercise of the options at a pre-fixed price may be interpreted by the market as a sign of his belief in the partnership's intrinsic value and its ability to generate future returns.

The report to the Israel Securities Authority details that this was a single transaction and that the full monetary consideration was paid in full on the date the change was executed. The partnership reported the event to the authorities the day after it occurred, in accordance with regulations. The move makes Sultan an even more dominant and influential figure in the partnership's ownership structure, signaling to the market his continued active involvement.